Unternehmen

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

To learn more about Lilly, please visit us at www.lilly.co.uk.

Adresse

Lilly House
Basing View
Basingstoke
Hampshire
United Kingdom
RG21 4FA

Kontakt

Telefon für medizinische Informationen
+44-(0)1256-315000

Servicezeiten
Mon-Fri 10am - 4pm (excl. bank holidays)

Unternehmenswebseite
https://www.lillymedical.co.uk/en-gb

E-Mail für medizinische Informationen
ukmedinfo@lilly.com

Live chat

Unerwünschte Nebenwirkungen & Produktbeschwerden

Please do not use this website to report side effects or product complaints.

If you experience side effects, talk to your doctor or other healthcare professional. This includes any possible side effects not listed in the package leaflet. To report a side effect or product complaint with a Lilly product please call Lilly UK on 01256 315000. Additionally, reporting forms and further information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple

Ein unerwünschtes Ereignis melden Telefon
44-(0)1256-315000

Healthcare Professionals can submit medical enquiry URL:
https://www.lillymedical.eu/en-gb/submitquestion

Company website:
https://www.lilly.co.uk

Lilly Produkte

Arzneimittel, die mit einemgekennzeichnet sind, unterliegen einer zusätzlichen Überwachung. Dies ermöglicht eine schnelle Identifizierung neuer Sicherheitsinformationen. Sie können helfen, indem Sie mögliche Nebenwirkungen melden.

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z

Abasaglar®
(Insulin glargine)

Adcirca®
(tadalafil)

Alimta®
(pemetrexed)

Cialis®
(tadalafil)

Cymbalta®
(duloxetine)

Cyramza®
(ramucirumab)

Emgality®
(galcanezumab)

Forsteo®
(teriparatide)

Humalog®
(human insulin analogue)

Humulin®
(human insulin)

Lyumjev®
(insulin lispro)

Mounjaro®
(tirzepatide)

Olumiant®
(baricitinib)

Omvoh®
(mirikizumab)

Retsevmo®
(selpercatinib)

Strattera®
(atomoxetine)

Taltz®
(ixekizumab)

Trulicity®
(dulaglutide)

Verzenios®
(abemaciclib)

Yentreve®
(duloxetine)

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z
Letzte Aktualisierung: 01.05.2024